Gritstone bio, Inc. (NASDAQ: GRTS) reported Q2 EPS of ($0.16), $0.12 better than the analyst estimate of ($0.28). Revenue for the quarter came in at $920 thousand versus the consensus estimate of $1.9 million.

For earnings history and earnings-related data on Gritstone bio, Inc. (GRTS) click here.